Acrivon Therapeutics, Inc. news ACRV
Plain-English coverage of this company’s material 8-K filings — generated from the primary source the moment they file.
← back to Acrivon Therapeutics, Inc.-
Moderate Neutral
Acrivon Therapeutics (ACRV) Adopts New Equity Plan
The company established an incentive stock plan authorizing up to 8.6 million shares for employee and director awards.